Detalhe da pesquisa
1.
Levels of IgE sensitization drive symptom thresholds in allergic rhinitis.
Ann Allergy Asthma Immunol
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679157
2.
TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
Allergy
; 77(7): 2131-2146, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038351
3.
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study.
Allergy Asthma Proc
; 42(3): 235-242, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980337
4.
Genetics and Epigenetics in Asthma.
Int J Mol Sci
; 22(5)2021 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33673725
5.
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis.
Int Arch Allergy Immunol
; 181(8): 613-617, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32570256
6.
Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses.
Proc Natl Acad Sci U S A
; 114(14): E2891-E2900, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28320933
7.
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
Eur Respir J
; 54(3)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467120
8.
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study.
Clin Exp Allergy
; 54(4): 286-290, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084474
9.
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response.
Allergy
; 77(9): 2848-2852, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595723
10.
T2-low asthma: current approach to diagnosis and therapy.
Curr Opin Pulm Med
; 23(1): 48-55, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798418
11.
Collapse phenomenon during Chartis collateral ventilation assessment.
Eur Respir J
; 47(6): 1657-67, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076587
12.
Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.
Eur Respir J
; 47(3): 769-82, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869672
13.
The Role of Biomarkers in Lung Cancer Screening.
Cancers (Basel)
; 16(11)2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38893101
14.
Inhaler adherence in severe asthma: is there an electronic solution?
Eur Respir J
; 51(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301915
15.
Activin-A exerts a crucial anti-inflammatory role in neonatal infections.
Pediatr Res
; 74(6): 675-81, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24002335
16.
Successful and safe treatment of severe steroid depended eosinophilic asthma with mepolizumab in a woman during pregnancy.
Respir Med Case Rep
; 41: 101785, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466584
17.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
JTO Clin Res Rep
; 4(1): 100433, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793384
18.
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
ERJ Open Res
; 9(2)2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020841
19.
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.
Ther Adv Med Oncol
; 14: 17588359221122728, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36105886
20.
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
J Allergy Clin Immunol Pract
; 10(10): 2588-2595, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752436